Suplementação e uso terapêutico de vitamina D nos pacientes com esclerose múltipla: Consenso do Departamento Científico de Neuroimunologia da Academia Brasileira de Neurologia

  • Brum D
  • Comini-Frota E
  • Vasconcelos C
 et al. 
  • 30


    Mendeley users who have this article in their library.
  • 4


    Citations of this article.


Multiple sclerosis (MS) is an inflammatory, autoimmune, demyelinating,
and degenerative central nervous system disease. Even though the
etiology of MS has not yet been fully elucidated, there is evidence that
genetic and environmental factors interact to cause the disease. Among
the main environmental factors studied, those more likely associated
with MS include certain viruses, smoking, and hypovitaminosis D. This
review aimed to determine whether there is evidence to recommend the use
of vitamin D as monotherapy or as adjunct therapy in patients with MS.
We searched PUBMED, EM BASE, COCHRANNE, and LILACS databases for studies
published until September 9th, 2013, using the keywords ``multiple
sclerosis{''} ``vitamin D{''}, and ``clinical trial{''}. There is no
scientific evidence up to the production of this consensus for the use
of vitamin D as monotherapy for MS in clinical practice.

Author-supplied keywords

  • Experimental autoimmune encephalitis
  • Multiple sclerosis
  • Vitamin D

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free